Innovative* Wearable Capnograph For All Patients

MARIE - The Future of Respiratory Monitoring. Wearable Capnograph For All Patients.

Overview

Testimonials

”Being able to measure and monitor respiratory rate in a simple and technically reliable way with MARIE has the potential to save many patients’ lives. I see significant and important areas of application in healthcare for this medical product in the future.”

Anna Cedborg, Medical Doctor, PhD, Specialist in Anesthesiology & Intensive Care, Head of Clinic at Remeo, Stockholm, Sweden
Anna Cedborg

Medical Doctor, PhD, Specialist in Anesthesiology & Intensive Care, Head of Clinic at Remeo, Stockholm, Sweden

”For the neurologically ill, MARIE would be useful for non-invasively investigating the need for BiPAP at home and the patient would then not need to visit the hospital to check the Arterial Blood Gas (ABG).

Also, one would probably get a much more representative value if registration can be done continuously during the night than just checking an ABG at 9 am the next morning.”

Johan Virhammar, Medical Doctor and Associate Professor of Neurology, Uppsala University Hospital, Sweden
Johan Virhammar

Medical Doctor and Associate Professor of Neurology, Uppsala University Hospital, Sweden

”Performing frequent ETCO2 spot checks on homecare COPD patients and continuously telemetry monitoring of patients in the ward using a wearable pulse oximetry and capnography solution would help recognize trending warnings signs early on and thus improving the outcome for the patients.”

Christian Karagiannidis, Medical Doctor and Professor, Critical Care & Emergency Medicine, Cologne, Germany
Christian Karagiannidis

Medical Doctor and Professor, Critical Care & Emergency Medicine, Cologne, Germany

Wearable Capnography for All Patients

MARIE vs. 1st Generation Wearable Capnographs

For OEM and Distribution Partners

Team

Joakim Östblom, CEO
Joakim Östblom

Anders Eckerbom, CTO
Anders Eckerbom

Pia Sundström, COO
Pia Sundström

Peter Karlsson, QA/RA
Peter Karlsson

Gustav Hoppe

Board of Directors

Lennart Käll (Chair)

Mikael Lönn
Helén Hedebark

Anders Eckerbom

Joakim Östblom


News & Updates

Nov 2024

MARIE showcased at MEDICA, Düsseldorf

Nov 2024
Feb 2025

MARIE first clinical trial completed at the ambulance

Feb 2025
Q1 2026

Expected FDA 510(k) clearance and CE-mark certification

Q1 2026

Address
E-mail